Dapamac M 10mg/1000mg Tablet ER
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (1000mg)
Overview Dapamac M 10mg/1000mg Tablet ER
Dapamac M 10mg/1000mg Extended-Release tablets combine two medications to manage type 2 diabetes. This dual-action therapy helps regulate elevated blood glucose, minimizing the risk of severe diabetic complications and contributing to heart health protection. Dapamac M can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation should only occur under their guidance, as abrupt cessation could elevate blood sugar, potentially leading to kidney problems or vision loss. This medication forms part of a comprehensive diabetes management plan, incorporating dietary adjustments, physical activity, and weight management as directed by your doctor. Commonly reported side effects include throat irritation, nasal stuffiness, rhinorrhea, headache, nausea, emesis, and diarrhea. Adequate hydration is crucial to prevent dehydration. Genital yeast infections may occur; meticulous hygiene can mitigate this risk. Prior to commencing treatment, disclose any kidney, liver, or urinary tract issues, diuretic use, or pregnancy/breastfeeding status to your doctor. Limiting alcohol consumption is advisable to reduce potential side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Dapamac M 10mg/1000mg Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Dapamac M 10mg/1000mg Tablet ER
Managing type 2 diabetes
Major Benefits of Dapamac M 10mg/1000mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapamac M 10mg/1000mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
Common Side effects of Dapamac M 10mg/1000mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapamac M 10mg/1000mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapamac M 10mg/1000mg Extended-Release tablets should be administered with a meal.
How Dapamac M 10mg/1000mg Tablet ER works:
Dapagliflozin and metformin, combined as Dapamac M 10mg/1000mg Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates glucose excretion via the urine, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual-action approach leads to superior glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapamac M 10mg/1000mg Extended-Release Tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Dapamac M 10mg/1000mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against any possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapamac M 10mg/1000mg tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with impaired kidney function should use Dapamac M 10mg/1000mg Extended-Release tablets cautiously. Dosage modification of Dapamac M 10mg/1000mg Extended-Release tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Dapamac M 10mg/1000mg Extended-Release tablets. Dosage modification of Dapamac M 10mg/1000mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Dapamac M 10mg/1000mg Tablet ER :
Should you forget to take your Dapamac M 10mg/1000mg Extended-Release tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapamac M 10mg/1000mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |




